SB-0744, As Passed House, December 17, 2009
SUBSTITUTE FOR
SENATE BILL NO. 744
A bill to amend 1956 PA 218, entitled
"The insurance code of 1956,"
(MCL 500.100 to 500.8302) by adding section 3829a.
THE PEOPLE OF THE STATE OF MICHIGAN ENACT:
Sec. 3829a. (1) This section applies to all medicare
supplement policies or certificates delivered, issued for delivery,
or
renewed on or after May 21, 2009.
(2) An insurer of a medicare supplement policy or certificate
shall
not do either of the following:
(a) Deny or condition the issuance or effectiveness of the
policy or certificate, including the imposition of any exclusion of
benefits under the policy based on a preexisting condition, on the
basis of the genetic information with respect to that individual.
(b) Discriminate in the pricing of the policy or certificate,
including the adjustment of premium rates, of an individual on the
basis
of the genetic information with respect to that individual.
(3) Nothing in subsection (2) limits the ability of an
insurer, to the extent otherwise permitted by law, from doing
either of the following:
(a) Denying or conditioning the issuance or effectiveness of a
policy or certificate or increasing the premium for a group based
on the manifestation of a disease or disorder of an insured or
applicant.
(b) Increasing the premium for any policy issued to an
individual based on the manifestation of a disease or disorder of
an individual who is covered under the policy. However, the
manifestation of a disease or disorder in 1 individual cannot be
used as genetic information about other group members and to
further increase the premium for the group.
(4) An insurer of a medicare supplement policy or certificate
shall not request or require an individual or a family member of
that
individual to undergo a genetic test.
(5) Subsection (4) does not preclude an insurer of a medicare
supplement policy or certificate from obtaining and using the
results of a genetic test in making a determination regarding
payment, as defined for the purposes of applying the regulations
promulgated under part C of title XI and section 264 of the health
insurance portability and accountability act of 1996, 42 USC 1320d
to
1320d-8, and consistent with subsection (2).
(6) For purposes of carrying out subsection (5), an insurer of
a medicare supplement policy or certificate may request only the
minimum amount of information necessary to accomplish the intended
purpose.
(7) Notwithstanding subsection (4), an insurer of a medicare
supplement policy may request, but not require, that an individual,
or a family member of that individual, undergo a genetic test if
each
of the following conditions is met:
(a) The request is made pursuant to research that complies
with 45 CFR part 46, or equivalent federal regulations, and any
applicable state or local law or regulations for the protection of
human
subjects in research.
(b) The insurer clearly indicates to each individual, or in
the case of a minor child, to the legal guardian of that child, to
whom the request is made, that compliance with the request is
voluntary and that noncompliance will have no effect on enrollment
status
or premium or contribution amounts.
(c) Genetic information collected or acquired under this
subsection shall not be used for underwriting, determination of
eligibility to enroll or maintain enrollment status, premium rates,
or the issuance, renewal, or replacement of a policy or
certificate.
(d) The insurer notifies the commissioner in writing that the
insurer is conducting activities pursuant to the exception provided
for under this subsection, including a description of the
activities conducted.
(e)
The insurer complies with any other conditions as the
commissioner may by regulation require for activities conducted
under
this subsection.
(8) An insurer of a medicare supplement policy or certificate
shall not request, require, or purchase genetic information for
underwriting
purposes.
(9) An insurer of a medicare supplement policy or certificate
shall not request, require, or purchase genetic information with
respect to any individual prior to that individual's enrollment
under
the policy in connection with that enrollment.
(10) If an insurer of a medicare supplement policy or
certificate obtains genetic information incidental to the
requesting, requiring, or purchasing of other information
concerning any individual, that request, requirement, or purchase
is not a violation of subsection (9) if that request, requirement,
or purchase does not violate subsection (8).
(11) As used in this section:
(a) "Family member" means, with respect to an individual, any
other individual who is a first-degree, second-degree, third-
degree,
or fourth-degree relative of that individual.
(b) "Genetic information" means, with respect to any
individual, information about that individual's genetic tests, the
genetic tests of family members of that individual, and the
manifestation of a disease or disorder in family members of that
individual. Genetic information includes, with respect to any
individual, any request for, or receipt of, genetic services, or
participation in clinical research which includes genetic services,
by that individual or any family member of that individual. Any
reference to genetic information concerning an individual or family
member of an individual who is a pregnant woman includes genetic
information of any fetus carried by that pregnant woman or, with
respect to an individual or family member utilizing reproductive
technology, includes genetic information of any embryo legally held
by an individual or family member. Genetic information does not
include
information about the sex or age of any individual.
(c) "Genetic services" means a genetic test, genetic
counseling, including obtaining, interpreting, or assessing genetic
information,
or genetic education.
(d) "Genetic test" means an analysis of human DNA, RNA,
chromosomes, proteins, or metabolites, that detect genotypes,
mutations, or chromosomal changes. Genetic test does not mean an
analysis of proteins or metabolites that does not detect genotypes,
mutations, or chromosomal changes; or an analysis of proteins or
metabolites that is directly related to a manifested disease,
disorder, or pathological condition that could reasonably be
detected by a health care professional with appropriate training
and expertise in the field of medicine involved.
(e) "Insurer of a medicare supplement policy or certificate"
includes a third-party administrator or other person acting for or
on behalf of that insurer.
(f) "Underwriting purposes" means all of the following:
(i) Rules for, or determination of, eligibility, including
enrollment and continued eligibility, for benefits under the
policy.
(ii) The computation of premium or contribution amounts under
the policy.
(iii) The application of any preexisting condition exclusion
under the policy.
(iv) Other activities related to the creation, renewal, or
replacement
of a contract of health insurance or health benefits.
Enacting section 1. This amendatory act does not take effect
unless House Bill No. 5235 of the 95th Legislature is enacted into
law.